These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 38605400)

  • 1. METTL3-Mediated N6-methyladenosine mRNA Modification and cGAS-STING Pathway Activity in Kidney Fibrosis.
    Tsai YC; Hsieh TH; Liao YR; Tsai MT; Lin TP; Lee DY; Park J; Kim D; Susztak K; Yang SF; Lin CC; Li SY
    J Am Soc Nephrol; 2024 Jun; ():. PubMed ID: 38857203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRPM4 mRNA stabilization by METTL3-mediated m6A modification promotes calcific aortic valve inflammation.
    Wu J; Huang H; Yang W; Xue T; Wang W; Zheng GD
    Heliyon; 2024 Jun; 10(11):e31871. PubMed ID: 38868032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Mettl3 ameliorates osteoblastic senescence by mitigating m6A modifications on Slc1a5 via Igf2bp2-dependent mechanisms.
    Liu XW; Xu HW; Yi YY; Zhang SB; Chang SJ; Pan W; Wang SJ
    Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(7):167273. PubMed ID: 38844111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PAK1 Promotes Inflammation Induced by Sepsis through the Snail/CXCL2 Signaling Pathway.
    Chen M; Pan L; Chen D; Wu Y; Ye J; Li K; Zhang N; Xu J
    ACS Infect Dis; 2024 Apr; 10(4):1370-1378. PubMed ID: 38503263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The N6-methyladenosine Epitranscriptomic Landscape of Lung Adenocarcinoma.
    Wang S; Zeng Y; Zhu L; Zhang M; Zhou L; Yang W; Luo W; Wang L; Liu Y; Zhu H; Xu X; Su P; Zhang X; Ahmed M; Chen W; Chen M; Chen S; Slobodyanyuk M; Xie Z; Guan J; Zhang W; Khan AA; Sakashita S; Liu N; Pham NA; Boutros PC; Ke Z; Moran MF; Cai Z; Cheng C; Yu J; Tsao MS; He HH
    Cancer Discov; 2024 Jun; ():. PubMed ID: 38922581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N6-methyladenosine modification and post-translational modification of epithelial-mesenchymal transition in colorectal cancer.
    Wang Y; Chen Y; Zhao M
    Discov Oncol; 2024 Jun; 15(1):209. PubMed ID: 38834851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. METTL3 recruiting M2-type immunosuppressed macrophages by targeting m6A-SNAIL-CXCL2 axis to promote colorectal cancer pulmonary metastasis.
    Ouyang P; Li K; Xu W; Chen C; Shi Y; Tian Y; Gong J; Bao Z
    J Exp Clin Cancer Res; 2024 Apr; 43(1):111. PubMed ID: 38605400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer.
    Yue B; Song C; Yang L; Cui R; Cheng X; Zhang Z; Zhao G
    Mol Cancer; 2019 Oct; 18(1):142. PubMed ID: 31607270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SNAIL Induces EMT and Lung Metastasis of Tumours Secreting CXCL2 to Promote the Invasion of M2-Type Immunosuppressed Macrophages in Colorectal Cancer.
    Bao Z; Zeng W; Zhang D; Wang L; Deng X; Lai J; Li J; Gong J; Xiang G
    Int J Biol Sci; 2022; 18(7):2867-2881. PubMed ID: 35541899
    [No Abstract]   [Full Text] [Related]  

  • 10. SUMO1 modification of methyltransferase-like 3 promotes tumor progression via regulating Snail mRNA homeostasis in hepatocellular carcinoma.
    Xu H; Wang H; Zhao W; Fu S; Li Y; Ni W; Xin Y; Li W; Yang C; Bai Y; Zhan M; Lu L
    Theranostics; 2020; 10(13):5671-5686. PubMed ID: 32483411
    [No Abstract]   [Full Text] [Related]  

  • 11. METTL3 promotes colorectal carcinoma progression by regulating the m6A-CRB3-Hippo axis.
    Pan J; Liu F; Xiao X; Xu R; Dai L; Zhu M; Xu H; Xu Y; Zhao A; Zhou W; Dang Y; Ji G
    J Exp Clin Cancer Res; 2022 Jan; 41(1):19. PubMed ID: 35012593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. METTL3/IGF2BP2 axis affects the progression of colorectal cancer by regulating m6A modification of STAG3.
    Yi J; Peng F; Zhao J; Gong X
    Sci Rep; 2023 Oct; 13(1):17292. PubMed ID: 37828232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic colorectal cancer: mechanisms and emerging therapeutics.
    Shin AE; Giancotti FG; Rustgi AK
    Trends Pharmacol Sci; 2023 Apr; 44(4):222-236. PubMed ID: 36828759
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.